Overexpression of Grb2-associated binder 2 in human lung cancer.

Overexpression of Grb2-associated binder 2 in human lung cancer.
复制标题

DOI:
10.7150/ijbs.7.496
复制
发表时间:
2011-04-18
影响因子:
9.2
通讯作者:
Li JW
Li JW
中科院分区:
生物学2区
文献类型:
--
作者:
Xu XL;Wang X;Chen ZL;Jin M;Yang W;Zhao GF;Li JW

文献摘要

参考文献

被引文献

相似文献

目的:Grb2-associated binder 2 (Gab2)是gabb支架接头家族的一员,其作用是传递和放大来自受体酪氨酸激酶的信号。最近的一项研究表明,Gab2在乳腺癌和转移性黑色素瘤中过度表达,Gab2是一种致癌蛋白。然而,Gab2在肺癌中的作用在很大程度上是未知的。方法:为了探讨Gab2的表达是否可能是肺癌的一个特征,本研究采用定量实时荧光定量pcr、免疫组织化学和western blot技术分析了88例肺组织冷冻标本和122例石蜡包埋组织标本中Gab2的表达。结果:我们发现,经免疫组化检测,肿瘤组织中Gab2的阳性表达率在鳞状细胞癌中为62.5%,在腺癌中为51.35%,在其他类型肺癌中为75%,明显高于正常肺组织(12%)。实时荧光定量pcr检测各组mRNA表达和western blotting检测各组蛋白表达与免疫组化结果一致。结论:我们的数据表明,与正常肺组织相比,Gab2在恶性肺组织中过表达,提示Gab2的表达可能在肺癌的发生发展中发挥作用。
Objective: Grb2-associated binder 2 (Gab2), a member of the family of Gab scaffolding adaptors, transmits and amplifies the signals from receptor tyrosine kinases. A recent study demonstrated that Gab2 was over-expressed in breast cancers and metastatic melanomas, and Gab2 was an oncogenic protein. However, the roles of Gab2 in lung cancers are largely unknown. Method: In this study, to investigate whether Gab2 expression could be a characteristic of lung cancers, we analyzed the expression of Gab2 in 88 lung frozen tissue samples and 122 paraffin-embedded tissue specimens, using quantitative real-time-PCR, immunohistochemistry and western blot. Results: We found that the positive expression rate of Gab2 in the tumor tissues, as detected by immunohistochemistry, 62.5% in squamous cell cancers, 51.35% in adenocarcinomas, and 75% in other types of lung cancers, was significantly higher than that (12%) in normal lung tissues. The mRNA expression detected by quantitative real-time-PCR and protein expression detected by western blotting in different groups were consistent with the immunohistochemical results. Conclusion: Our data indicate that Gab2 is over-expressed in malignant lung tissues compared with that in normal lung tissues, and suggest that Gab2 expression may play a role in lung cancer development.
DOI: 10.1038/sj.onc.1210315
发表时间: 2007-07-01
期刊: ONCOGENE
影响因子: 8
作者:
Ke, Y.;Wu, D.;Feng, G-S
通讯作者: Feng, G-S
DOI: 10.1023/a:1023033708204
发表时间: 2003-04-01
影响因子: 3.8
作者:
Ormandy, CJ;Musgrove, EA;Sutherland, RL
通讯作者: Sutherland, RL
DOI: 10.1002/ijc.25172
发表时间: 2010-09-15
影响因子: 6.4
作者:
Fleuren, Emmy D. G.;O'Toole, Sandra;Daly, Roger J.
通讯作者: Daly, Roger J.
DOI: 10.2353/ajpath.2009.080543
发表时间: 2009-04-01
影响因子: 6
作者:
Horst, Basil;Gruvberger-Saal, Sofia K.;Celebi, Julide Tok
通讯作者: Celebi, Julide Tok
DOI: 10.1002/path.1681
发表时间: 2005-01-01
影响因子: 7.3
作者:
Lambros, MBK;Fiegler, H;Tomlinson, IPM
通讯作者: Tomlinson, IPM